Text Size

April 2015 Excerpt


Underway locally

Several local care transition projects are focused on reducing ADEs:

Eastern Idaho Community
Standardized patient health record (includes a medication list)

Magic Valley Community
"Know What you Take" patient outreach campaign

Providence St. Peter Hospital, Olympia
Pharmacist-led "Medication Concierge" service for patients about to be discharged

Let us know what ADE-focused interventions your community has begun!

Use these interventions to prevent adverse drug events

As we reported in the January Monthly Briefing, active surveillance is crucial to understanding adverse drug events (ADEs). After you gather information about the ADEs and potential ADEs occuring in your community, and complete some preliminary root cause analyses, it is time to develop interventions aimed at prevention.

Two common sources of ADEs include incomplete information transfer when a patient moves through various healthcare settings and providers, and patients not understanding the why and how of each medicine they are taking. Relevant interventions are outlined below.

Information Transfer

Enlist clinical pharmacists, discharge planners, or other staff to perform a medication review with patients. The MATCH toolkit and MARQUIS Implementation Manual both provide detailed guidelines for developing policies and performing systematic medication reconciliation. (These interactions also provide opportunities to capture data about ADEs and pADEs that the patient may have already experienced.)

Patient Education and Activation

Use the Teach Back method to ensure that patients understand instructions about the safe use and purpose of their medications.

Distribute personal medication lists to patients. There's no need to recreate the wheel as many organizations have already developed effective versions. (See examples.)

Interview various members of your coalition or neighboring communities (see sidebar) to learn about interventions that have worked with specific subpopulations. For information about developing an assessment to identify patients most at risk for ADEs, see page 61 of the MARQUIS manual.